15 May 2023
Frontier Developments plc
EBT Share Purchase
Frontier Developments plc (AIM: FDEV, "Frontier", the "Company") was notified on 12 May 2023, by Ocorian Limited, the trustee of the Frontier Developments plc Employee Benefit Trust (the "EBT"), that the EBT had purchased 68,623 ordinary shares of 0.5p each in the Company ("Ordinary Shares") at an average price of 533 pence per Ordinary Share on 12 May 2023. These Ordinary Shares are to be held in the EBT and are intended to be used to satisfy the exercise of share options by employees. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company. The purchase of Ordinary Shares by the EBT has been funded from the Company's existing cash resources.
Following this transaction, a total of 473,714 Ordinary Shares are held by the EBT, representing approximately 1.20 per cent of the Company's total voting rights.
Enquiries:
Frontier Developments +44 (0)1223 394 300
Jonny Watts, CEO
Alex Bevis, CFO
Liberum - Nomad and Joint Broker +44 (0)20 3100 2000
Andrew Godber / Nikhil Varghese
Jefferies - Joint Broker +44 (0)20 7029 8000
Philip Noblet / William Brown
Tulchan Communications +44 (0)20 7353 4200
Matt Low / Mark Burgess / Alex Dart
About Frontier Developments plc
Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.
Frontier's LEI number: 213800B9LGPWUAZ9GX18.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
